Most Herceptin side effects are temporary, lasting a few days to a few weeks after each infusion. But the drug stays in your body for up to 20 weeks after your final dose, and some effects, particularly on the heart, can take months to fully resolve. How long you feel side effects depends on which ones you experience and whether you’re receiving Herceptin alone or alongside chemotherapy.
How Long Herceptin Stays in Your Body
Herceptin (trastuzumab) has a half-life of roughly 28.5 days, meaning it takes about a month for your body to clear just half of the drug from your system. The full washout period is up to 20 weeks (about five months) after your last infusion. This is important because side effects can continue as long as the drug is still circulating, even after treatment officially ends.
This long washout also explains why your oncology team continues monitoring you after your final dose. The drug doesn’t simply stop working the day you leave the infusion center for the last time.
Infusion Reactions: Hours, Not Days
The most immediate side effects happen during or shortly after an infusion, especially the first one. Fever, chills, nausea, and headache are common. These reactions typically start about an hour into the infusion and resolve the same day. In a study tracking infusion reactions, all patients had complete resolution of symptoms after the infusion was temporarily paused and supportive medications were given. About 79% of reactions required pausing the infusion for an average of 54 minutes.
First infusions are the most likely to cause these reactions. Subsequent infusions tend to go more smoothly, which is why first infusions are given over a longer period (90 minutes) while later ones can be shortened to 30 minutes.
Fatigue: The Slowest Side Effect to Fade
Fatigue is one of the most persistent complaints during and after Herceptin treatment. Research tracking fatigue in breast cancer patients found a sharp increase in the first six months of treatment, followed by a slow decline that levels off at around two years after diagnosis. For some people, fatigue lingers even several years after treatment ends.
This timeline is complicated by the fact that most people receiving Herceptin also undergo surgery, radiation, or chemotherapy. Fatigue from these overlapping treatments stacks together, making it difficult to isolate what Herceptin alone contributes. If you’re receiving Herceptin with a taxane-based chemotherapy, expect fatigue to be more pronounced during active treatment and slower to resolve afterward.
Heart-Related Effects: Reversible but Worth Watching
Cardiac side effects are the most medically significant concern with Herceptin. The drug can reduce your heart’s pumping efficiency, measured by something called the left ventricular ejection fraction (LVEF). Unlike heart damage caused by certain older chemotherapy drugs, Herceptin-related heart changes are not dose-dependent and are reversible in most patients once treatment stops.
Complete or partial heart function recovery occurs in about 86% of patients who develop symptomatic heart problems during Herceptin therapy. Recovery typically happens over weeks to months after the drug is discontinued, though a small percentage of patients experience lasting changes. Current guidelines recommend heart imaging every three months during treatment to catch any decline early. For patients on lower-risk regimens that don’t include anthracycline chemotherapy, recent evidence suggests monitoring every six months may be equally safe.
If your heart function does drop during treatment, your oncologist will likely pause Herceptin and start standard heart failure medications. Most people can resume treatment once their heart function improves, though this decision is made case by case.
Joint Pain, Muscle Aches, and Other Common Effects
Joint and muscle pain are frequently reported during Herceptin treatment. These tend to follow a pattern similar to other mild side effects: they appear within a few days of an infusion and typically ease within one to two weeks. For most people, they don’t worsen with each cycle the way some chemotherapy side effects do.
Other common mild effects like diarrhea, headache, and mild skin reactions also fall into the “days to weeks” category. They generally resolve on their own between infusion cycles and stop altogether within weeks of your final treatment, though they can technically persist until the drug fully clears your system at around 20 weeks.
When Herceptin Is Combined With Chemotherapy
Most people don’t receive Herceptin in isolation. It’s commonly paired with chemotherapy drugs, and this combination changes the side effect picture significantly. Adding Herceptin to chemotherapy increases the risk of low white blood cell counts, infections, and anemia compared to chemotherapy alone. These are primarily chemotherapy-driven effects, but Herceptin amplifies them.
Nerve-related side effects like numbness or tingling in the hands and feet (peripheral neuropathy) come from the chemotherapy component rather than Herceptin itself. These can persist for months or even years after chemotherapy ends, so if you’re experiencing lingering numbness well after your Herceptin course, the chemotherapy is the more likely culprit. The practical takeaway: when assessing how long your side effects will last, it helps to understand which drug is causing which symptom, since their timelines differ.
Rare Lung-Related Effects
In uncommon cases, Herceptin-related drugs can cause inflammation in the lungs (interstitial lung disease). When this occurs in breast cancer patients, it tends to appear at a median of about 193 days into treatment, with a wide range from 42 to 535 days. Once identified and treated, recovery takes a median of 34 days, though some cases resolve in as few as three days while others take up to six months.
This is a rare but serious side effect. Symptoms include a new or worsening cough, shortness of breath, or difficulty breathing that feels out of proportion to your activity level. It’s distinct from the everyday fatigue and mild breathlessness that many people experience during cancer treatment.
A Rough Timeline to Expect
- During infusion: Fever, chills, and nausea resolve within hours, usually the same day.
- Between infusions: Headache, joint pain, diarrhea, and mild effects typically last days to two weeks.
- First few months after final dose: Fatigue gradually improves. Heart function, if affected, recovers in most patients within this window.
- Up to 20 weeks after final dose: The drug is still present in your body. Lingering mild effects can persist until full clearance.
- Six months to two years after treatment: Fatigue continues to slowly improve. Most people feel close to their baseline energy levels by the two-year mark, though some report residual fatigue beyond that.